Anastasios D Papanastasiou Selected Research

Keratin-7 (Cytokeratin 7)

1/2023

Histologic and genomic characterization of a primary mucinous carcinoma of the skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasios D Papanastasiou Research Topics

Disease

12	Neoplasms (Cancer) 02/2024 - 05/2011
6	Breast Neoplasms (Breast Cancer) 11/2022 - 07/2012
3	Inflammation (Inflammations) 01/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 05/2011
1	Laron Syndrome (Syndrome, Laron) 09/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Xerostomia 10/2018
1	Keratoconjunctivitis Sicca 10/2018
1	Adenomyoepithelioma 01/2018
1	Infections 11/2014
1	Chromothripsis 03/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Necrosis 07/2012
1	Abscess 04/2010
1	Cysts 04/2010
1	Job Syndrome (Hyper-IgE Syndrome) 04/2010
1	Pneumonia (Pneumonitis) 04/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2022 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2010
2	Estrogen ReceptorsIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
2	AutoantibodiesIBA 01/2022 - 10/2018
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 10/2017
2	Codon (Codons)IBA 01/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2017
1	Cell-Free Nucleic AcidsIBA 02/2024
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 09/2023
1	Keratin-7 (Cytokeratin 7)IBA 01/2023
1	Periodic AcidIBA 01/2023
1	MucinsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	TNF Receptor-Associated Factor 3IBA 11/2022
1	OsteopontinIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	resiquimodIBA 01/2022
1	LipofuscinIBA 01/2022
1	LipidsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Gefitinib (Iressa)FDA Link 10/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	CytokinesIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2018
1	CoagulaseIBA 11/2014
1	NucleotidesIBA 03/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	MitogensIBA 01/2014
1	NF-kappa B (NF-kB)IBA 07/2012
1	LigandsIBA 07/2012
1	Protein Isoforms (Isoforms)IBA 07/2012
1	DCC ReceptorIBA 05/2011
1	Netrin-1IBA 05/2011
1	Immunoglobulin E (IgE)IBA 04/2010
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2010
1	AntigensIBA 10/2008
1	EpitopesIBA 10/2008
1	AutoantigensIBA 10/2008

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2008
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Neoadjuvant Therapy 01/2020
1	Immunotherapy 01/2014
1	Stem Cell Transplantation 10/2008